Cross-Sector entity
COSMOS Trial is most often covered alongside Haleon, which appears in 2 of these 3 stories. Coverage clusters in clinical-trial, which accounts for 1 of those 3, with the remainder spread across 2 other categories. COSMOS Trial appears in 3 tracked Cross-Sector stories from March 9, 2026.
3 verified stories tracked
Last mentioned: Mar 9, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 67 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
COSMOS Trial is most often covered alongside Haleon, which appears in 2 of these 3 stories. Coverage clusters in clinical-trial, which accounts for 1 of those 3, with the remainder spread across 2 other categories. COSMOS Trial appears in 3 tracked Cross-Sector stories from March 9, 2026. The tracked stories average 20.3 original sources each.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering COSMOS Trial. Shared-story counts are live from our verified record — not editorial picks.
Biological Aging Analysis
New data confirms daily supplements slow the ticking of the biological aging clock in older adults.
Biological Aging Data
New analysis links multivitamin use to slower epigenetic aging markers.
COSMOS-Clinic Update
In-person clinical assessments reinforce cognitive aging slowing by 3 years.
COSMOS-Web Study
Research published in the American Journal of Clinical Nutrition linked multivitamins to improved memory.
COSMOS-Web Study
Large-scale web-based study confirms memory benefits of daily supplements.
COSMOS-Mind Results
Initial findings show multivitamins improve cognition in older adults.
Cognitive & Clinical Results
Initial findings on memory and cardiovascular outcomes published with mixed results.
Initial COSMOS Results
Early data focused on cardiovascular and cancer outcomes showed neutral results for multivitamins.
COSMOS Trial Launch
Large-scale randomized trial begins investigating cocoa extract and multivitamins.
A significant new clinical study indicates that daily multivitamin supplementation may slow biological aging in older adults by approximately two years. The findings suggest that consistent micronutrient intake supports cellular health and mitigates the epigenetic markers associated with age-related decline.
A prespecified analysis of the large-scale COSMOS trial has found that daily multivitamin-multimineral supplementation significantly slows markers of biological aging in older adults. The study provides robust clinical evidence that standard nutritional interventions can influence cellular longevity and epigenetic health beyond simple deficiency prevention.
A prespecified analysis of the COSMOS trial reveals that daily multivitamin-multimineral supplements significantly slow markers of biological aging in older adults. The findings provide clinical weight to the use of common supplements as a low-cost intervention for extending biological healthspan.
Source: MedPage Today · miragenews.com
